Review
Clinical Neurology
Konark Malhotra, Christina Zompola, Aikaterini Theodorou, Aristeidis H. Katsanos, Ashkan Shoamanesh, Himanshu Gupta, Simon Beshara, Nitin Goyal, Jason Chang, Ashis H. Tayal, Efstathios Boviatsis, Konstantinos Voumvourakis, Charlotte Cordonnier, David J. Werring, Andrei V. Alexandrov, Georgios Tsivgoulis
Summary: Among patients with spontaneous intracerebral hemorrhage, approximately 1 in 4 cases have undetermined etiology, leading to a relatively high short-term mortality rate. Cerebral amyloid angiopathy accounts for the largest hemorrhage volume, while hypertensive arteriopathy and undetermined ICH have smaller volumes.
Article
Neurosciences
Mengke Zhang, Ruiwen Che, Wenbo Zhao, Hailiang Sun, Changhong Ren, Jin Ma, Wenbo Hu, Milan Jia, Chuanjie Wu, Xin Liu, Xunming Ji
Summary: This study aimed to explore the relationship between computed tomography (CT)-based cerebral small vessel disease (SVD) markers and the clinical outcomes in patients with cerebral amyloid angiopathy (CAA)-related intracerebral hemorrhage (ICH). The results showed that the SVD markers based on CT could predict the short-term outcome more effectively in patients with CAA-ICH. Further studies are needed to validate these findings and identify modifiable factors for preventing CAA-ICH development.
CNS NEUROSCIENCE & THERAPEUTICS
(2023)
Article
Clinical Neurology
Sabine Voigt, Siham Amlal, Emma A. Koemans, Ingeborg Rasing, Ellis S. van Etten, Erik W. van Zwet, Mark A. van Buchem, Gisela M. Terwindt, Marianne A. A. van Walderveen, Marieke J. H. Wermer
Summary: The study investigated the topographical and temporal patterns of index and recurrent intracerebral hemorrhages in Dutch-type hereditary Cerebral Amyloid Angiopathy (D-CAA). Results showed a preference for occipital lobe in both index and recurrent ICHs, with no acceleration in time nor gradual increase of hematoma volume between subsequent ICHs.
INTERNATIONAL JOURNAL OF STROKE
(2022)
Article
Clinical Neurology
Aayushi Garg, Santiago Ortega-Gutierrez, Mudassir Farooqui, Nandakumar Nagaraja
Summary: This study found that patients with intracerebral hemorrhage (ICH) and concomitant cerebral amyloid angiopathy (CAA) are three times more likely to have readmissions for recurrent ICH compared to patients without CAA.
JOURNAL OF NEUROLOGY
(2022)
Review
Clinical Neurology
Howard Kirshner, Matthew Schrag
Summary: Intracerebral hemorrhage (ICH) accounts for 15% of all strokes in the US, yet almost 50% of fatal strokes. The most common causes are hypertension and cerebral amyloid angiopathy. Treatment focuses on managing edema, reducing blood pressure, and correcting coagulopathy. Current standard of care includes supportive therapies, but there is no definitive curative therapy like mechanical thrombectomy for ischemic stroke. New medical and surgical approaches show promise in improving ICH management.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
(2021)
Article
Clinical Neurology
Yuyi Zhu, Lu Liu, Luyao Zhong, Yajun Cheng, Shihong Zhang, Bo Wu, Deren Wang, Mangmang Xu
Summary: The study aims to investigate the association between burden of cerebral small vessel disease (CSVD) caused by hypertensive angiopathy (HA) and cerebral amyloid angiopathy (CAA) on MRI in patients with primary intracerebral hemorrhage (ICH). The results showed a significant association between HA-CSVD and CAA-CSVD, which needs to be confirmed in future studies.
FRONTIERS IN NEUROLOGY
(2023)
Article
Clinical Neurology
Simon Fandler-Hoefler, Thomas Gattringer, Christian Enzinger, David J. Werring
Summary: This study found that patients with probable CAA who were diagnosed using the Boston v2.0 criteria had a lower risk of ICH recurrence compared to those diagnosed using the v1.5 criteria.
Article
Clinical Neurology
Evangelos Pavlos Myserlis, Christopher D. Anderson, Marios K. Georgakis
Summary: Recent evidence suggests that higher CRP levels are associated with lower risk of Alzheimer disease, and this study explores whether genetically proxied CRP levels are also associated with lobar intracerebral hemorrhage (ICH) caused by cerebral amyloid angiopathy. The results show that higher genetically proxied CRP levels are associated with lower odds of lobar ICH, supporting the hypothesis that high CRP levels may have a protective role in amyloid-related pathology.
Article
Medicine, General & Internal
Russell P. Sawyer, Stacie L. Demel, Mary E. Comeau, Miranda Marion, Jonathan Rosand, Carl D. Langefeld, Daniel Woo
Summary: Apolipoprotein E alleles are associated with both Alzheimer's disease and intracerebral hemorrhage; intracerebral hemorrhage has a high risk of subsequent dementia; variations in CR1 and CLU genes are associated with an increased risk of lobar ICH.
Article
Clinical Neurology
Joan Marti-Fabregas, Pol G. Camps-Renom, Jonathan G. Best, Anna Ramos-Pachon, Marina Guasch-Jimenez, Alejandro Martinez-Domeno, Daniel M. Guisado-Alonso, Beatriz M. Gomez-Anson, Gareth Ambler, Duncan Wilson, Keon-Joo Lee, Jae-Sung Lim, Hee-Joon Bae, Masayuki Shiozawa, Masatoshi Koga, Kazunori G. Toyoda, Michael G. Hennerici, Hugues Chabriat, Eric Jouvent, Debbie Yuen Kwun Wong, Henry Mak, Kui Kai Lau, Young Dae Kim, Tae-Jin Song, Ji-Hoe Heo, Sebastian Eppinger, Thomas Gattringer, Ender Uysal, Derya Selcuk Demirelli, Natan Bornstein, Einor Ben Assayag, Hen A. Hallevi, Jeremy A. Molad, Masashi Nishihara, Jun Tanaka, Hideo Hara, Yusuke B. Yakushiji, Shelagh B. Coutts, Eric A. Smith, Alexandros A. Polymeris, Benjamin Wagner, David A. Seiffge, Philippe A. Lyrer, Nils T. Peters, Stefan T. Engelter, Rustam Al-Shahi Salman, Hans Rudolf Jager, Gregory Y. H. Lip, Martina Goeldlin, Leonidas Panos, Christopher Charles G. Karayiannis, Thanh G. K. Phan, Velandai K. Srikanth, Nicolas Christ, Sarah Gunkel, Felix W. Fluri, Thomas W. Leung, Yannie O. Y. Soo, Winnie Chu, Jill Abrigo, Carmen Barbato, Simone Browning, Robert Simister, Anne-Marie Mendyk, Regis Bordet, Saima Hilal, Bibek Gyanwali, Christopher Chen, Simon Jung, Dilek Necioglu Orken, David Werring, Luis Prats-Sanchez
Summary: This study aimed to investigate the risk of future cerebrovascular events in patients with ischemic stroke (IS) or transient ischemic attack (TIA) and cortical superficial siderosis (cSS), as well as the benefits and safety of antithrombotic drugs for secondary prevention. The study found that cSS was associated with an increased risk of stroke, and the risk of IS was higher than that of intracranial hemorrhage (ICrH) in patients receiving antiplatelet or anticoagulant treatment alone, while the risk of ICrH was higher than that of IS in patients receiving both treatments. Therefore, the study suggests that using antiplatelet or anticoagulant drugs alone is safe in patients with cSS, but combined antithrombotic therapy might be hazardous.
Article
Clinical Neurology
Giuseppe Scopelliti, Barbara Casolla, Gregoire Boulouis, Gregory Kuchcinski, Solene Moulin, Didier Leys, Hilde Henon, Charlotte Cordonnier, Marco Pasi
Summary: Anxiety is common among survivors of spontaneous intracerebral hemorrhage (ICH), often occurring together with depressive symptoms even years after the initial event. Lobar ICH location is significantly associated with anxiety 1-2 years after ICH.
INTERNATIONAL JOURNAL OF STROKE
(2022)
Article
Clinical Neurology
Hsin-Hsi Tsai, Szu-Ju Chen, Li-Kai Tsai, Marco Pasi, Yen-Ling Lo, Ya-Fang Chen, Sung-Chun Tang, Jiann-Shing Jeng
Summary: This study compared clinical data and follow-up outcomes of patients with mixed ICH, CAA-ICH, and HTN-ICH, and found that mixed ICH has a higher risk of unfavorable vascular outcome compared to HTN-ICH. The presence of cortical superficial siderosis (cSS) in mixed ICH independently predicts vascular events, suggesting a detrimental effect due to coexisting CAA.
Review
Clinical Neurology
Mangmang Xu, Yuyi Zhu, Xindi Song, Xuelian Zhong, Xinxin Yu, Deren Wang, Yajun Cheng, Wendan Tao, Bo Wu, Ming Liu
Summary: In this systematic review and meta-analysis, we investigated the relationship between cerebral amyloid angiopathy (CAA) and arteriolosclerosis in intracerebral hemorrhage (ICH) patients. We also compared the MRI and pathological changes of markers of cerebral small vessel disease (CSVD). The results indicated that severe CAA was potentially associated with arteriolosclerosis. Patients with evidence of CAA had a higher number of microbleeds compared to those without CAA. However, further research is needed to explore the pathological changes of CSVD markers according to the etiology of ICH.
TRANSLATIONAL STROKE RESEARCH
(2023)
Article
Medicine, General & Internal
Carmen Barbato, Piergiuseppe Liuzzi, Anna Maria Romoli, Francesca Draghi, Daniela Maccanti, Andrea Mannini, Claudio Macchi, Francesca Cecchi, Bahia Hakiki
Summary: This study found that sporadic CAA associated with cerebral hemorrhage is independently associated with poorer rehabilitation outcomes, regardless of age. This suggests the importance of improving knowledge about CAA to better predict rehabilitation outcomes.
Review
Clinical Neurology
Xinglei Jia, Menghan Bo, Hong Zhao, Jia Xu, Luqian Pan, Zhengyu Lu
Summary: Cerebral amyloid angiopathy (CAA) related intracerebral hemorrhage (ICH) has a high recurrence rate, and risk factors associated with recurrence include previous ICH, baseline ICH volume, subarachnoid hemorrhage, cortical superficial siderosis, disseminated cortical superficial siderosis, and centrum semiovale-perivascular spaces severity.
FRONTIERS IN NEUROLOGY
(2023)
Article
Neurosciences
Yasuteru Inoue, Shoji Honda, Masaki Watanabe, Yukio Ando
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
(2015)
Article
Neurosciences
Yasuteru Inoue, Shoji Honda, Masaki Watanabe, Yukio Ando
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
(2015)
Article
Neurosciences
Yasuteru Inoue, Fumio Miyashita, Kazuo Minematsu, Kazunori Toyoda
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
(2018)
Article
Neurosciences
Yosuke Takeuchi, Keiichi Nakahara, Makoto Nakajima, Yasuteru Inoue, Riyo Matsumura, Munekage Yamaguchi, Hidetaka Katabuchi, Yukio Ando
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
(2019)
Review
Biochemistry & Molecular Biology
Yasuteru Inoue, Yukio Ando, Yohei Misumi, Mitsuharu Ueda
Summary: Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of amyloid beta (Aβ) in brain vessels, leading to vessel fragility, hemorrhages, and neurological symptoms. The pathogenesis of CAA is not fully understood, but recent advances in mass spectrometric methodology have identified potential key molecules associated with CAA. Understanding the interactions between cerebrovascular Aβ deposits and these molecules may lead to the development of effective CAA therapeutics.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Yasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Toshiya Nomura, Yukio Ando, Mitsuharu Ueda
Summary: In this study, the researchers found that α-enolase (ENO1) can interact with amyloid beta (Aβ) and inhibit its fibril formation. They also demonstrated that ENO1 can disrupt Aβ fibrils and weaken their cytotoxic effects by degrading Aβ peptides. Additionally, infusion of ENO1 into mouse brains reduced cerebrovascular Aβ deposits and improved cognitive impairment. These findings suggest that ENO1 may be a therapeutic target in cerebral amyloid angiopathy (CAA).
CELLULAR AND MOLECULAR LIFE SCIENCES
(2022)